NEW YORK and MAINZ, GERMANY, December 16, 2021 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) to…Original Article
Pfizer and BioNTech Submit Supplemental Biologics License Application for U.S. FDA Approval of Comirnaty in Adolescents 12 Through 15 Years of Age
